Reuters logo
9 个月前
BRIEF-Ra Pharmaceuticals reports Q3 loss per share $14.22
2016年11月29日 / 晚上9点27分 / 9 个月前

BRIEF-Ra Pharmaceuticals reports Q3 loss per share $14.22

Nov 29 (Reuters) - Ra Pharmaceuticals Inc

* Ra Pharmaceuticals reports third quarter 2016 financial results and provides corporate update

* Q3 loss per share $14.22

* Q3 earnings per share view $-0.72 -- Thomson Reuters I/B/E/S

* On track to initiate phase 2 clinical trial of ra101495 in q1 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below